FDA campaign H-0348-2026
Class IIHazard
Unapproved drug claims on product labeling and product misbranded due to no Supplement Facts label
Distribution
AL, AZ, CA, GA, IL, IN, MN, MO, MS, NC, NY, TN
REKALLD area-alert coverage: AL, AZ, CA, GA, IL, IN, MN, MO, MS, NC, NY, TN (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.